Overview

Memantine Therapy for Multiple Sclerosis

Status:
Terminated
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy of Memantine in improving the cognitive impairment in patients with Multiple Sclerosis (MS)
Phase:
Phase 2
Details
Lead Sponsor:
Clinica Universidad de Navarra, Universidad de Navarra
Collaborator:
H. Lundbeck A/S
Treatments:
Memantine